earnings
CR
NASDAQ · CRIS
Curis, Inc.
Healthcare · Biotechnology
$1.49
Down-$0.07 (-4.70%)
Updated Sep 1, 2026, 11:04 PM
SID Score
4.9/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 16.68M
- P/E ratio
- -0.55
- Dividend yield
- 0.00%
- 52-week range
- $0.18 – $11.40
- Volume
- 35.84K
- Avg. volume
- 86.2K
Price performance
CRIS price history
1M range · 21 trading sessions · Daily adjusted prices
CRIS closed at $1.49 after 21 trading sessions, down 71.07% for the selected period.
- Last close
- $1.49
- Period change
- -71.07%
- Period low
- $1.49
- Period high
- $5.15
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 31, 2026 | $1.48 | $1.53 | $1.4085 | $1.49 | 35.84K |
| Aug 28, 2026 | $1.51 | $1.58 | $1.45 | $1.49 | 119.83K |
| Aug 27, 2026 | $1.56 | $1.5892 | $1.40 | $1.50 | 288.29K |
| Aug 26, 2026 | $1.59 | $1.6099 | $1.51 | $1.54 | 105.41K |
| Aug 25, 2026 | $1.61 | $1.64 | $1.55 | $1.59 | 142.44K |
| Aug 24, 2026 | $1.60 | $1.65 | $1.5109 | $1.58 | 83.11K |
| Aug 21, 2026 | $1.63 | $1.6595 | $1.50 | $1.58 | 212.51K |
| Aug 20, 2026 | $1.71 | $1.715 | $1.59 | $1.61 | 133.88K |
| Aug 19, 2026 | $1.72 | $1.75 | $1.65 | $1.72 | 196.45K |
| Aug 18, 2026 | $1.83 | $1.93 | $1.68 | $1.70 | 282.12K |
| Aug 17, 2026 | $2.03 | $2.03 | $1.752 | $1.80 | 367.79K |
| Aug 14, 2026 | $1.83 | $2.08 | $1.74 | $1.80 | 470.55K |
| Aug 13, 2026 | $1.58 | $2.08 | $1.54 | $1.87 | 2.29M |
| Aug 12, 2026 | $2.33 | $2.40 | $1.63 | $1.67 | 1.15M |
| Aug 11, 2026 | $3.20 | $3.37 | $2.29 | $2.31 | 600.78K |
| Aug 10, 2026 | $4.07 | $4.15 | $3.5001 | $3.66 | 72.95K |
| Aug 7, 2026 | $4.35 | $4.35 | $3.955 | $4.02 | 70.02K |
| Aug 6, 2026 | $4.49 | $4.6999 | $4.02 | $4.41 | 78.96K |
| Aug 5, 2026 | $4.84 | $5.0633 | $4.39 | $4.545 | 54.59K |
| Aug 4, 2026 | $5.14 | $5.2799 | $4.6129 | $4.72 | 85.58K |
| Aug 3, 2026 | $5.13 | $5.50 | $5.06 | $5.15 | 84.51K |
Latest CRIS news
The latest Smart Investors Daily articles mentioning CRIS.
Stock researchCompany · Financials
Loading stock research…